PISANI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 2946
EU - Europa 2052
AS - Asia 524
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 5532
Nazione #
US - Stati Uniti d'America 2941
SE - Svezia 664
CN - Cina 506
UA - Ucraina 379
DE - Germania 284
IT - Italia 256
FI - Finlandia 180
GB - Regno Unito 96
FR - Francia 81
PL - Polonia 37
AT - Austria 22
BE - Belgio 22
RU - Federazione Russa 13
IR - Iran 9
NL - Olanda 9
CH - Svizzera 5
CA - Canada 3
EU - Europa 3
IN - India 3
JP - Giappone 3
AU - Australia 2
CL - Cile 2
ES - Italia 2
MX - Messico 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 5532
Città #
Jacksonville 807
Chandler 620
Nyköping 251
Beijing 232
Dearborn 186
Princeton 186
Cambridge 176
Des Moines 146
Medford 122
Ann Arbor 116
Boardman 90
Woodbridge 47
Wilmington 45
San Mateo 40
Shenyang 40
Warsaw 36
Jinan 33
Messina 30
Nanjing 27
Bremen 22
Brussels 22
Vienna 22
Houston 21
Hebei 20
Ashburn 18
Tianjin 18
Seattle 17
Norwalk 16
Ningbo 15
Zhengzhou 15
Jiaxing 14
Lancaster 13
Haikou 12
Fuzhou 11
Hangzhou 11
Rome 11
Ardabil 9
Taizhou 8
Nanchang 7
Augusta 6
Taiyuan 6
Auburn Hills 5
Caserta 5
Clearwater 5
Guangzhou 5
Milan 5
Verona 5
Amsterdam 4
Changsha 4
Faenza 4
Helsinki 4
Leawood 4
Pozzo Di Gotto 4
Bari 3
Bronte 3
Kemerovo 3
Kunming 3
Lanzhou 3
Los Angeles 3
Redwood City 3
Riva 3
Saint Petersburg 3
San Giuliano 3
Alessandria 2
Catania 2
Cedar Knolls 2
Dong Ket 2
Foggia 2
Hefei 2
Kriens 2
Lodi 2
Manfredonia 2
Massa Fiscaglia 2
Mexico City 2
Monmouth Junction 2
Montecchio 2
Mumbai 2
Napoli 2
Strasbourg 2
Toronto 2
Adliswil 1
Aiello Del Sabato 1
Altamura 1
Aquila 1
Atlanta 1
Auckland 1
Baotou 1
Barzanò 1
Battipaglia 1
Berlin 1
Cairo 1
Canosa Di Puglia 1
Capo D'orlando 1
Cardano 1
Civitanova Marche 1
Codevilla 1
Duncan 1
Elk Grove Village 1
Falls Church 1
Fano 1
Totale 3682
Nome #
" Stato confusionale di probabile natura iatrogena"; " Verosimile screzio psicotico"; " Sindrome Cefalalgica"; " Disturbo d'Ansia". Varie ipotesi ed una sola diagnosi: SENC 126
Rischio di iperomocisteinemia in pazienti con Epilessia, portatori del diplotipo C677T/A1298C della MTHFR 98
Distribuzione di due polimorfismi genici della MTHFR in pazienti con Epilessia e correlazione con i livelli serici di omocisteina 87
FORCED NORMALISATION: OBSERVATION WITH NEW ANTIEPILEPTIC DRUGS 65
Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs. 55
Il concetto di normalizzazione forzata in epilettologia 54
Ruolo dei farmaci antiepilettici nella neuroprotezione da ischemia cerebrale 53
THE EFFECT OF COMBINING VIGABATRIN AND TIAGABINE, TWO DRUGS WITH COMPLEMENTARY GABAERGIC MECHANISMS, AGAINST NMDA-INDUCED EXCITOTOXICITY 52
Carbamazepine-viloxazine interaction in patients with epilepsy 52
FORCED NORMALISATION: A RETROSPECTIVE ANALYSIS OF RISK FACTORS 51
Effetto della viloxazina sui livelli ematici di oxcarbazepina e dei relativi metaboliti 51
ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY 50
Effect of viloxazine on serum carbamazepine levels in epileptic patients 50
beneficial effect of donezepil in a malnourished surgical patient with severe nonalcoholic wernicke's encephalopathy 50
CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION 49
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 49
Prime esperienze su efficacia e tollerabilità della tiagabina in pazienti con epilessia farmacoresistente 49
Objective cognitive dysfunction assessment in patients with subjective cognitive complaints: does it allow an early differentiation between demnetia and pseudo-dementia? 46
A sensitive gas chromatograpic assay for the determination of serum viloxazine concetration using a nitrogen-phosphorus selective detector". Ther. Drug Monit., 6:484-488, 1984. 45
Effects of psychotropic drugs on seizure threshold 44
Aspetti neuropsichiatrici dell'epilessia 44
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 44
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia 43
Hyperhomocysteinemia in patients with epilepsy: does it play a role in the pathogenesis of brain atrophy? A preliminary report. 43
"Valproic acid-amitriptyline interaction in man 43
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 43
The effect of lamotrigine on peripheral nerves. 42
INFLUENCE OF COMEDICATION ON THE METABOLISM OF VALPROATE 42
Antiepileptic drugs and MTHFR Polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients 42
An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis 42
Neuroprotective effects of levetiracetam against kainic acid toxicity are mediated by inhibition of lipid peroxidation 41
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico. 40
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study 40
VIGABATRIN-INDUCED DECREASE IN SERUM PHENYTOIN CONCENTRATION DOES NOT INVOLVE A CHANGE IN PHENYTOIN BIOAVAILABILITY 39
THE INFLUENCE OF ELECTROENCEPHALOGRAPHIC FOCUS LATERALITY ON EFFICACY OF CARBAMAZEPINE IN COMPLEX PARTIAL AND SECONDARILY GENERALIZED TONIC-CLONIC SEIZURES 39
ELEVATION OF PLASMA PHENYTOIN BY VILOXAZINE IN EPILEPTIC PATIENTS - A CLINICALLY SIGNIFICANT DRUG-INTERACTION 39
Pharmacokinetics and therapeutic plasma monitoring of antiepileptic drugs 38
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction 38
Le terapie associative in epilettologia 38
Single-dose kinetics of primidone in acute viral hepatitis 38
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 38
EFFECTS OF THE ANTIDEPRESSANT DRUG VILOXAZINE ON OXCARBAZEPINE AND ITS HYDROXYLATED METABOLITES IN PATIENTS WITH EPILEPSY 37
Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide 37
Valproic acid-ethosuximide interaction: A pharmacokinetic study 37
Is retinal assessment useful in epileptic patients with hyperhomocysteinemia? 37
Diurnal fluctuations in plasma drug levels:studies with valproic acid and carbamazepine 37
INTERACTION OF LAMOTRIGINE WITH SODIUM VALPROATE 36
Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study 36
SOCIAL ASPECTS OF EPILEPSY IN THE ADULT IN SEVEN EUROPEAN COUNTRIES 36
CLINICALLY RELEVANT ANTI-EPILEPTIC DRUG-INTERACTIONS 36
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration 36
null 36
Differential interactions of valproic acid and valpromide with Carbamazepine in man 36
Clinical and pharmacokinetic study of conventional carbamazepine vs a new controlled-release (CR) formulation: a double-blind, cross-over trial 36
Controllo totale di crisi con l’associazione lamotrigina-gabapentin in un caso di epilessia sintomatica. 36
Repetitive transcranial magnetic stimulation induced slow wave activity modification: A possible role in disorder of consciousness differential diagnosis? 36
Specific Patient Features Affect Antiepileptic Drug Therapy Decisions: Focus on Gender, Age, and Psychiatric Comorbidities 36
Morbidity in patients with epilepsy: type and complications: a European cohort study 35
Normalizzazione forzata e fattori di rischio: un'analisi retrospettiva 35
Limited place for plasma monitoring of new antiepileptic drugs in clinicalpractice. 35
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients 34
The 894G > T (Glu298Asp) variant in the endothelial NOSgene and MTHFR polymorphisms influence homocysteine levels in patients withcognitive decline. 34
Liquid chromatographic assay of lamotrigine,a new antiepileptic drug, by a hig-speed column 33
Valproic acid fails to displace phenobarbitone and carbamazepine from plasma protein binding sites in epileptic patients 33
Sodium valproate and valpromide:Differential interactions with carbamazepine in epileptic patients 33
Evaluation of Tricyclic Antidepressant Plasma Levels by an Automated Enzyme Immunoassay (EMIT) in Comparison to a High-Performance Liquid Chromatographic Method 33
Il significato del monitoraggio dei farmaci nella compliance 33
A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats 33
ATTENTION CHARACTERIZATION IN PATIENTS WITH FRONTAL AND TEMPORAL LOBE EPILEPSY 33
The importance of drug interactions in epilepsy therapy 32
Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: aprospective observational study. 32
LAMOTRIGINE IN REFRACTORY EPILEPSY - A LONG-TERM OPEN STUDY 32
Identification of amoebae in the CSF in a patient with meningoencephalitis. 32
Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment 32
Phenylethylmalonamide in essential tremor.A double-blind controlled study 32
Increased dipropylacetic acid bioavailability from dipropylacetamide by food 32
Crisi epilettiche indotte dall’assunzione di leflunamide in pazienti in terapia con carbamazepina 32
Attivita' parossistica ed agenti farmacologici: attivazione ed inibizione 32
LAMOTRIGINE IN RESISTANT CHILDHOOD EPILEPSY 31
SAFETY AND EFFICACY OF VIGABATRIN AND CARBAMAZEPINE IN NEWLY DIAGNOSED EPILEPSY:A MULTICENTER RANDOMISED DOUBLE-BLIND STUDY 31
Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina 31
INTERACTION OF CARBAMAZEPINE-10,11-EPOXIDE, AN ACTIVE METABOLITE OF CARBAMAZEPINE, WITH VALPROATE - A PHARMACOKINETIC STUDY 31
Distribution of attention in normal people as a function of spatial location: Right-left, up-down 31
CONTRIBUTION OF INTERICTAL BRAIN PERFUSION SPECT IN ASSESSING PATIENTS WITH EPILEPSY 31
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico 31
Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis 31
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies 30
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 30
PHARMACOKINETICS OF A VALPROMIDE ISOMER, VALNOCTAMIDE, IN HEALTHY-SUBJECTS 30
Ipsilesional attentional-approach neglect or crossover effect 30
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 30
Plasticità e neuroprotezione tra evidenze sperimentali ed insuccessi terapeutici. Ipotesi operative e finalità del Gruppo di Studio SIN 29
LIQUID-CHROMATOGRAPHIC ANALYSIS OF ANTIEPILEPTIC DRUGS - AN OVERVIEW 29
Relationship between serum mono-hydroxy-carbazepine concentrations and adverseeffects in patients with epilepsy on high-dose oxcarbazepine therapy. 29
Levetiracetam protects against kainic acid-induced toxicity 29
Prevenzione dell’epilettogenesi: revisione della letteratura, raccomandazioni terapeutiche, proposte di ricerca 29
COULD LAMOTRIGINE BE USEFUL IN STATUS EPILEPTICUS - A CASE- REPORT 28
Recurrent status epilepticus as the main feature of Hashimoto's encephalopathy 28
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction 28
Pharmacokinetics of a valproic acid isomer, valnoctamide, in healthy subjects 28
Totale 3960
Categoria #
all - tutte 10885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10885


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018306 0000 00 1657 3091859
2018/2019287 77136 16035 149 57177
2019/20201364 19885781 17183 203140 2815424424
2020/2021991 146720255 39162 16102 16978861
2021/20221104 191652142 223 6554 25152192344
2022/20231228 23216893210 248253 240 0000
Totale 5613